CD3zeta down-modulation may explain Vgamma9Vdelta2 T lymphocyte anergy in HIV-infected patients

J Infect Dis. 2009 Feb 1;199(3):432-6. doi: 10.1086/596047.

Abstract

The aim of the present study was to explain the observed anergy of Vgamma9Vdelta2 T cells from human immunodeficiency virus (HIV)-positive patients. CD3zeta expression and interferon (IFN)-gamma production by Vgamma9Vdelta2 T cells from HIV-positive and HIV-negative subjects were analyzed. We demonstrated that Vgamma9Vdelta2 T cells from HIV-infected patients expressed a lower level of CD3zeta than did Vgamma9Vdelta2 T cells from healthy donors. A direct correlation was found between CD3zeta expression and IFN-gamma production capability by Vgamma9Vdelta2 T cells. However, activation of protein kinase C by phorbol myristate acetate is able to restore CD3zeta expression and IFN-gamma production. Our findings may contribute to clarification of the molecular mechanisms of Vgamma9Vdelta2 T cell anergy found in HIV-positive patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • CD3 Complex / genetics
  • CD3 Complex / metabolism*
  • Case-Control Studies
  • Clonal Anergy*
  • Cytokines / genetics
  • Cytokines / metabolism
  • Female
  • Gene Expression Regulation
  • HIV Infections / immunology*
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Male
  • Middle Aged
  • T-Lymphocyte Subsets / immunology*
  • Young Adult

Substances

  • CD3 Complex
  • CD3 antigen, zeta chain
  • Cytokines
  • Interferon-gamma